|

Alzheimer's Disease Clinical Trials in Cleveland, OH

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2<1 mi
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Phase 2<1 mi
Learning Skills Together Family Caregiver Complex InterventionN/A<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 38 mi
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)Phase 210 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 310 mi
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADPhase 310 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisPhase 210 mi
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's TypePhase 310 mi
ACP-204 in Adults With Alzheimer's Disease PsychosisPhase 2/310 mi
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)—10 mi
[18F]PI-2620 Phase 3 Histopathological StudyPhase 310 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)—10 mi
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia—46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.